Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis

By sjmartinez • May 24, 2024

Zhang D, Hugo W, Bergsneider M, Wang MB, Kim W, Han K, Vinters HV, Heaney AP. Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis. Eur J Endocrinol. 2024 May 23:lvae055. doi: 10.1093/ejendo/lvae055. Epub ahead of print. PMID: 38781434.

Tags: Cabergoline, Dermatology, Endocrinology, Pituitary tumor, Prolactinomas, Publications, ScRNAseq, tumor microenvironment

Safety and Efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the Phase 2 STRIDE study

Papp KA, Jacobs S, Sofen H, Bukhalo M, Muscianisi E, Ma G, Lau G, Bettinger M, Rubio RG, Hitraya E, Blauvelt A; Open-Label Extension study[...]

Differentially Expressed Salivary miRNAs in Temporomandibular Disorders

Kaczor-Urbanowicz KE, Aziz M, Wilhalme H, Aronovich S, Hatfield ER, Aghaloo T, Arman S, Mohammadi A, Husain M, Tetradis S, Elashoff D, Pellegrini M, Wong[...]

Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm Presenting on the Breast of a 44-Year-Old Woman

Saka F, McKenzie S, Milani-Nejad N, Smart C. Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm Presenting on the Breast of a 44-Year-Old Woman. Am J[...]